Alpha-1

Alpha-1 is a genetic disorder identified by reduced levels of alpha-1 antitrypsin (A1AT) in the blood. A1AT is produced in the liver and works to protect the lungs from the neutrophil elastase enzyme. Without sufficient levels of A1AT, individuals can experience difficulty breathing and develop emphysema at a younger age. Alpha-1 patients may also lack the ability to secrete A1AT properly, resulting in excessive A1AT accumulation in the liver and, eventually, the development of liver cirrhosis. Alpha-1 can be treated through intravenous infusions of alpha-1 antitrypsin, derived from donated human plasma.

News and information about Alpha-1 products are included in the navigation on the left.

For more information about ordering Alpha-1 products, contact ASD Healthcare at 800-PHON-ASD (800-746-6273) or online at http://www.asdhealthcare.com.